Founder and Director
Tetrous
The startup develops demineralized bone fiber materials that promote tissue remodeling similar to natural bone-tendon enthesis, specifically targeting Enthesis Failure Syndrome. This technology enables surgeons to perform minimally disruptive procedures in rotator cuff workflows, enhancing biological performance and integration with existing surgical techniques.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$5.8MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops demineralized bone fiber materials that promote tissue remodeling similar to natural bone-tendon enthesis, specifically targeting Enthesis Failure Syndrome. This technology enables surgeons to perform minimally disruptive procedures in rotator cuff workflows, enhancing biological performance and integration with existing surgical techniques.